ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Santa Barbara At-Home Sleep Apnea Test: WatchPAT One Diagnosis System Announced

At Home Sleep Apnea Testing announces the Santa Barbara rollout of the FDA-cleared WatchPAT® One at-home sleep apnea assessment, designed to simplify diagnoses and expand access for adults who find in-lab sleep studies inconvenient or hard to schedule.

-- With growing attention on undiagnosed obstructive sleep apnea, At Home Sleep Apnea Testing has announced the availability of WatchPAT® One in Santa Barbara. The single-use, at-home device is designed to streamline testing for adults who may benefit from a Home Sleep Apnea Test (HSAT).

More details can be found at https://athomesleepapneatesting.com/innovation-in-the-night-latest-advances-in-sleep-apnea-treatment/

A representative explains that the organization's recent update reflects sustained demand for simpler pathways to diagnosis. The goal is to reduce delays tied to traditional overnight polysomnography, while supporting referring clinicians with clear, actionable reports intended to accelerate treatment decisions.

Research highlights both the scale of the condition and the role of home testing in appropriate patients. An analysis published in the American Journal of Respiratory and Critical Care Medicine estimated that moderate-to-severe sleep-disordered breathing affects roughly one-quarter of U.S. adults aged 30-70. The American Academy of Sleep Medicine also endorses home sleep apnea testing for uncomplicated adults with suspected OSA, alongside clinical evaluation.

WatchPAT® One incorporates peripheral arterial tonometry, pulse oximetry, and actigraphy in a lightweight form that attaches to the user's finger. The device and cloud workflow are designed to support accurate detection of respiratory events in the home environment, aiming to reduce barriers such as travel, overnight disruptions, and limited lab capacity that can discourage people from seeking help.

“Our aim is to make testing practical for everyday life, so people can move from suspicion to diagnosis without unnecessary obstacles,” the spokesperson explained. “Clinicians still direct care, but simpler testing can help more individuals get to that step.”

About At Home Sleep Apnea Testing

At Home Sleep Apnea Testing focuses on education and access pathways related to sleep apnea assessment. The organization highlights clinically informed workflows that align with published guidance, including HSAT for appropriate adults and referral for in-lab studies when indicated.

“I was contemplating doing a sleep study at a facility, but I am wary about sleeping at places I’m not used to,” one customer said. “I was researching at-home kits, and this one had amazing reviews. I took a dive, and it was an easy experience from start to finish. Less than a week to do the test and get a diagnosis.”

Interested parties can find more information by visiting https://athomesleepapneatesting.com/learn-more/

Contact Info:
Name: Ronald A. Popper, MD, FCCP, FAASM, DABSM
Email: Send Email
Organization: At Home Sleep Apnea Testing
Address: 317 S. Moorpark Rd, Thousand Oaks, CA 91361, Thousand Oaks, California 91361, United States
Website: https://athomesleepapneatesting.com/

Source: PressCable

Release ID: 89169720

If there are any deficiencies, problems, or concerns regarding the information presented in this press release that require attention or if you need assistance with a press release takedown, we encourage you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team is committed to promptly addressing your concerns within 8 hours and taking necessary actions to rectify any identified issues or facilitate the removal process. Providing accurate and trustworthy information is of utmost importance.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.